Foundry BioSciences

Foundry BioSciences, founded by cutting-edge scientists from MIT, Princeton, and Harvard, is a technology platform that leverages generative AI for protein design to empower the development of anti-aging products and drugs. The company focuses on utilizing advanced AI protein design technology to develop novel protein sequences with high bioactivity, applied in key areas of aging delay (including immune regulation, metabolic health, neuroprotection, and tissue regeneration). Core businesses include AI protein computation, consumer-grade health products, anti-aging drugs, and an open collaboration platform.